Immix Biopharma (IMMX) Earnings Date & Reports

Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

IMMX is expected to report earnings to rise 1.61% to -18 cents per share on December 02

Immix Biopharma IMMX Stock Earnings Reports

Q3'26

Est.

$-0.18

Q2'26

Est.

$-0.18

Q1'26

Beat

by $0.03

Q4'25

Missed

by $0.08

Q3'25

Missed

by $0.08

The last earnings report on September 02 showed earnings per share of -18 cents, missing the estimate of -17 cents. With 2.65M shares outstanding, the current market capitalization sits at 1.03B.

View a ticker or compare two or three

IMMX

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days